Vertex Pharmaceuticals Inc
Stock Details
Is it expensive?
Trailing P/E Ratio
28.14
Forward P/E Ratio
19.69
PEG Ratio
0.88
21.73
Price-to-Sales (TTM)
9.14
5.87
73.49
Market Cap
109.85B
105.75B
Is it profitable?
Net Profit Margin (TTM)
32.94%
Gross Profit Margin
85.39%
Diluted EPS (TTM)
15.33
22.54%
12.00B
Is it growing?
9.50%
30.50%
Is it risky?
0.37
10.91
2.90
2.04B
Who owns it?
97.62%
0.18%
1.83%
253.99M
253.24M
Does it pay?
0.00%
0.00%
--
--
How much cash?
6.61B
3.63B
2.57B
26.01
- Price
- 443.92
- Percent Change
- +12.06 (2.79%)
- Previous Close
- 431.86
- Open
- 437.43
- Low
- 432.36
- High
- 443.40
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$443.92
From 52W Low
+22.46%
From 52W High
-13.09%
Today
+2.79%
1Y Change
-7.96%
6M
$414.86
3M
$463.86
1M
$460.87
Today
$443.92
From 52W Low
+22.46%
From 52W High
-13.09%
Today
+2.79%
1Y Change
-7.96%
6M
$414.86
3M
$463.86
1M
$460.87
Today
$443.92
Fairly Priced
within its 1-year price range
$443.92
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-3.7%
3M
-4.3%
6M
+7.0%
1Y
-8.0%
Rate of Change (ROC)
Accelerating
Price is falling 12.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Vertex Pharmaceuticals Inc
- Founded
- Jan 1, 1989
- Founders
- Joshua Boger
- CEO
- Reshma Kewalramani
- Employees
- 6,400
- Fiscal Year End
- Dec 31, 2025
- Address
50 Northern Avenue
Boston
Massachusetts
02210
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.vrtx.com
Indicators
Operating Cash Flow
3.63B
Net Income
3.95B
Backed by Cash
0.92
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
3.63B
Net Income
3.95B
Backed by Cash
0.92
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
28.14
Forward P/E Ratio
19.69
PEG Ratio
0.88
21.73
Price-to-Sales (TTM)
9.14
5.87
73.49
Market Cap
109.85B
105.75B
Is it profitable?
Net Profit Margin (TTM)
32.94%
Gross Profit Margin
85.39%
Diluted EPS (TTM)
15.33
22.54%
12.00B
Is it growing?
9.50%
30.50%
Is it risky?
0.37
10.91
2.90
2.04B
Who owns it?
97.62%
0.18%
1.83%
253.99M
253.24M
Does it pay?
0.00%
0.00%
--
--
How much cash?
6.61B
3.63B
2.57B
26.01
- Price
- 443.92
- Percent Change
- +12.06 (2.79%)
- Previous Close
- 431.86
- Open
- 437.43
- Low
- 432.36
- High
- 443.40
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$443.92
From 52W Low
+22.46%
From 52W High
-13.09%
Today
+2.79%
1Y Change
-7.96%
6M
$414.86
3M
$463.86
1M
$460.87
Today
$443.92
From 52W Low
+22.46%
From 52W High
-13.09%
Today
+2.79%
1Y Change
-7.96%
6M
$414.86
3M
$463.86
1M
$460.87
Today
$443.92
Fairly Priced
within its 1-year price range
$443.92
Multi-Timeframe Analysis (MTA)
Downtrend
Most timeframes point down. One conflicting period introduces some uncertainty, but the overall direction is negative. Weaker than a Strong Downtrend, but still a bearish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-3.7%
3M
-4.3%
6M
+7.0%
1Y
-8.0%
Rate of Change (ROC)
Accelerating
Price is falling 12.3x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Vertex Pharmaceuticals Inc
- Founded
- Jan 1, 1989
- Founders
- Joshua Boger
- CEO
- Reshma Kewalramani
- Employees
- 6,400
- Fiscal Year End
- Dec 31, 2025
- Address
50 Northern Avenue
Boston
Massachusetts
02210
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.vrtx.com